Goldman Sachs and UBS have emerged as the leading mergers and acquisitions (M&A) financial advisers in South America for 2024, in terms of deal value and volume, respectively, according to the latest league table from GlobalData, a data and analytics firm.

UBS analyst Brennan Hawken raised the firm’s price target on Goldman Sachs (GS) to $640 from $610 and keeps a Neutral rating on the shares. The

The Goldman Sachs Group (NYSE:GS – Free Report) had its target price increased by UBS Group from $610.00 to $640.00 in a report issued on Tuesday morning,Benzinga reports.UBS Group currently has ...

Goldman Sachs (NYSE: GS) shares traded higher after reporting strong Q4 and full-year 2024 results. Revenue, EPS, and stock buybacks all beat expectations.

Goldman Sachs CEO David Solomon promoted a slew of top bankers on Tuesday to run the firm’s biggest business units, just days after the bank boss was awarded a pair of massive bonuses.

Analyst Ratings: In the last 15 days, Oppenheimer lowered Goldman Sachs stock price forecast from $677 to $639, UBS downgraded the stock to a Neutral rating with a price forecast of $610 ...

Goldman Sachs on Monday tapped veteran banker Stefan Duffner to lead the investment bank's activism and shareholder advisory work in Europe, Middle East and Africa (EMEA) at a time corporations are increasingly asking for help to defend against activist investors pushing for changes.

Piper Sandler adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) shares, reducing it from the previous $1,195.00 to $1,013.00. Despite this change, the firm maintained its Overweight rating on the biotech company's stock.

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share price rises for companies including Telix Pharmaceuticals, Clarity Pharmaceuticals and earlier-stage PYC Therapeutics.

In recent trading, TJX Companies Inc (TJX) stock price has shown some volatility, fluctuating 2.79% over the last five trades and 1.10% over the past 30 trades. This represents a notable shift from earlier in the year.

Stocks headed toward all-time highs as oil fell after President Donald Trump urged OPEC to lower crude prices and said he will push for interest-rate cuts.

Interactive Brokers Group, Inc. (IBKR) stock saw a modest uptick, ending the day at $209.78 which represents a slight increase of $16.95 or 8.79% from the prior close of $192.83. The stock opened at $207 and touched a low of $202.